No April Fool's joke: Cannabis legalization in Germany from April 2024

Today marks a historic month for the legalization of cannabis for personal use in Germany. A step that has inspired both critics and supporters of the plan. On April 1, the Cannabis Act (CanG) will come into force, ushering in a new era in Germany's drug policy. However, some jokingly wonder whether this is real progress or more of a April Fool's Day – A cause for joy or do they bring unforeseeable dangers?

The background of the CanG

On 23 February 2024, the Bundestag in Germany passed the CanG. A law on legalization the private and non-commercial cultivation of cannabis. This choice is based on the fact that the previous drug policy has reached its limits. In 2021, over four million people aged 18 to 64 consumed cannabis in Germany. Although there is a ban. Trade on the black market poses a significant health risk due to uncontrolled quality and unknown THC levels.

The aim of the CanG is to limit the illegal market, to monitor the quality of cannabis and thus improve health protection. At the same time, the government's educational and prevention work is being intensified to protect young people in particular.

 

Regulations and limits for self-construction

Adults in Germany are allowed to grow up to three cannabis plants from April 1st. However, it is necessary to protect the plants from access by children and young people. For example, in lockable cabinets or in rooms. A ban on advertising and sponsorship also applies to consumer cannabis and cultivation associations. Up to 25 grams of dried cannabis may be kept in public spaces. While up to 50 grams are allowed in private spaces (Federal Ministry of Health.

The establishment of so-called cannabis clubs or cultivation associations is permitted from July 1, 2024. These associations are considered non-commercial organizations with a maximum of 500 members. They must meet certain organizational and spatial conditions, such as a minimum distance to schools and childcare facilities.

The new law is being criticized despite the preventive measures it has taken. Opponents of the law, especially from the CSU and CDU, are pointing out the potential health risks, especially for young people under 25. They are also worried that cannabis could be seen as a gateway drug and that consumers could turn to more difficult drugs.

 

Cannabis and CBD

 

The debate about the legalization and legalization of cannabis in Germany remains controversial. Nevertheless, it is worth looking at another, less controversial component of the cannabis plant: CBD oil. Cannabidiol, also known as CBD CBD oil, also known as CBD, is a substance derived from the cannabis plant. However, it does not have the psychoactive effects of THC. In recent years, CBD oil has become increasingly popular due to its potential health benefits, which range from relaxation and pain relief to improving sleep.

The legalization of cannabis could also help to make CBD products more widely accepted and available. Unlike cannabis, which contains THC, CBD is not considered an intoxicant and is already legal in many countries. It must be emphasized that CBD oil and the now legalized cannabis for personal consumption are not the same. CBD oil is often valued for its therapeutic benefits without cannabis having any psychoactive effects.

This evolution in cannabis and CBD highlights the shift in society's attitude towards different types of cannabis products and opens up new possibilities for applications in the medical and wellness sectors. We could see an exciting time of progress and innovation in this area as acceptance increases and legislative changes become apparent.

 

THC & CBD – Effects on the Mind and Body

The combination of CBD and THC brings with it some fascinating benefits, especially in relation to the psychoactive effects associated with THC. CBD is considered non-psychoactive, so it can reduce the psychoactive effects of THC. This may be particularly beneficial for people who have a high sensitivity to THC or who experience negative side effects such as anxiety, paranoia or malaise after consuming THC.

A balanced ratio of THC to CBD can make the high more pleasant. For example, a 1:1 THC to CBD ratio will have an obvious psychoactive effect, but the CBD will compensate well, reducing the risk of anxiety, paranoia, and malaise. A 2:1 CBD to THC ratio would be ideal for people who find the traditional THC high unpleasant. In this situation, the high will be toned down by having twice the amount of CBD, resulting in a reduction in the intoxicating and potentially adverse effects of THC.

In addition, there is evidence that the combination of THC and CBD can provide medical benefits in some situations. It has therefore been proven that cannabis oil drops in conjunction with THC can combat nausea and vomiting. In addition, CBD also has positive effects on the fights and has anti-inflammatory properties that can be useful for skin problems such as acne. There are also promising methods for increasing energy and treating tumors that use CBD.

However, it should be taken into account that the consumption of cannabis products, including those containing CBD, carries risks and is not suitable for all age groups. Specific harm reduction measures, such as preventing the simultaneous use of tobacco and cannabis, can help reduce the risk. It is also advisable that people who regularly use cannabis make an effort to limit their consumption and be aware of the consequences for different areas of their lives. This is of particular importance for young people, pregnant women and people who have struggled with psychosis or substance use disorders in the past.

In general, cannabis products, whether they contain THC or CBD, should be consumed responsibly and at your own discretion to increase well-being and reduce risks.

 

Conclusion

There is no doubt that the legalization of cannabis in Germany from April 2024 represents an important step forward. It represents a paradigm shift in German drug policy that presents both opportunities and difficulties. Although it represents an opportunity to combat illicit trade and improve health protection, concerns remain about the protection of young people and possible abuse. Time will tell what impact this legislation will have on society in Germany.